Login / Signup

Five-Year Long-Term Results of Standard Collagen Cross-Linking Therapy in Patients with Keratoconus

Yelda Yıldız TaşcıAyşe Güzin Taşlıpınar UzelDemet ÖzdaşÖzge SaraçNurullah Cagil
Published in: Turkish journal of ophthalmology (2021)
In long-term follow-up, CCL treatment is seen to arrest keratoconus progression, increase vision, and improve visual quality by reducing higher-order aberrations and spherical aberrations. For these reasons, CCL treatment continues to be the first treatment modality in patients with progressive keratoconus.
Keyphrases
  • multiple sclerosis
  • copy number
  • cell proliferation
  • cell cycle
  • combination therapy